Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Examining genetic associations with hepatic steatosis in Mexican-origin adults. | Ann Hepatol | 2023 | 37271481 | PubTator, text mining | PubMed |
| Genetic risk of fatty liver disease and mortality in the general population: A Mendelian randomization study. | Liver Int | 2023 | 37269170 | PubTator, text mining | PubMed |
| Sample size calculation for a NanoString GeoMx spatial transcriptomics experiment to study predictors of fibrosis progression in non-alcoholic fatty liver disease. | Sci Rep | 2023 | 37268815 | PubTator, text mining | PubMed |
| Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach. | Nat Rev Gastroenterol Hepatol | 2023 | 37268740 | PubTator, text mining | PubMed |
| Progression to cirrhosis is similar among all ages in nonalcoholic fatty liver disease, but liver-related events increase with age. | Hepatol Commun | 2023 | 37267221 | PubTator, text mining | PubMed |
| Associations of Race and Ethnicity with Hepatocellular Carcinoma, Decompensation, and Mortality in US Veterans with Cirrhosis. | Cancer Epidemiol Biomarkers Prev | 2023 | 37255388 | PubTator, text mining | PubMed |
| Association of NAFLD with FGF21 Polygenic Hazard Score, and Its Interaction with Protein Intake Level in Korean Adults. | Nutrients | 2023 | 37242268 | PubTator, text mining | PubMed |
| Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease. | Nutrients | 2023 | 37242206 | PubTator, text mining | PubMed |
| PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies. | Molecules | 2023 | 37241755 | PubTator, text mining | PubMed |
| Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease. | J Pers Med | 2023 | 37241000 | PubTator, text mining | PubMed |
| Toward a New Era in the Management of Hepatocellular Carcinoma: Novel Perspectives on Therapeutic Options and Biomarkers. | Int J Mol Sci | 2023 | 37240362 | PubTator, text mining | PubMed |
| Genetic variants in HFE are associated with non-alcoholic fatty liver disease in lean individuals. | JHEP Rep | 2023 | 37235137 | PubTator, text mining | PubMed |
| A publication-wide association study (PWAS), historical language models to prioritise novel therapeutic drug targets. | Sci Rep | 2023 | 37225853 | PubTator, text mining | PubMed |
| Cross-tissue omics analysis discovers ten adipose genes encoding secreted proteins in obesity-related non-alcoholic fatty liver disease. | EBioMedicine | 2023 | 37224770 | PubTator, text mining | PubMed |
| Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease. | EXCLI J | 2023 | 37223084 | PubTator, text mining | PubMed |
| Lipid droplet biogenesis and functions in health and disease. | Nat Rev Endocrinol | 2023 | 37221402 | PubTator, text mining | PubMed |
| Alcohol-related hepatitis: A review article. | World J Gastroenterol | 2023 | 37213401 | PubTator, text mining | PubMed |
| An adult-based genetic risk score for liver fat associates with liver and plasma lipid traits in children and adolescents. | Liver Int | 2023 | 37208954 | PubTator, text mining | PubMed |
| Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database. | BMC Gastroenterol | 2023 | 37208593 | PubTator, text mining | PubMed |
| Association between PNPLA3 rs738409 variant and 5-year estimated glomerular filtration rate decline in post-menopausal women with type 2 diabetes: A panel-data analysis. | Nutr Metab Cardiovasc Dis | 2023 | 37208069 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=38